Videos

New survey results depict unexpected burdens in long-haul patients, as well as continued issues following rehabilitation.

An interview with a study author on new interpretations of biologic asthma benefit.

A discussion on continued research into the first regulated treatment for pediatric peanut allergy.

Unhealthy lifestyles during the pandemic may increase the risk of cardiovascular disease.

An expert discusses findings that showed voxelotor (Oxbryta) improved leg ulcers in patients with sickle cell disease.

Dr. Khan discusses some of the risk factors associated with CHD.

A Stanford Cardiovascular Institute expert details a recent review into managing a growing field of agents.

Two pediatric cardiologists stress that recognizing symptoms of MIS-C is essential for primary care providers.

Two pediatric cardiologists offer perspective on how to approach conversations about MIS-C with parents or guardians.

Dongngan Truong, MD, and Jane Newburger, MD, discuss the current clinical understanding of MIS-C.

Two experts offer perspectives on the importance and state of cardiovascular health in women.

Pending FDA decision, the Viaskin Peanut patch would be considered for lengthier benefit studies.

Anne Dixon, MD, explains how it took 6 years to update recommendations for new asthma therapies.

The epicutaneous immunotherapy for peanut allergy is continuing discussions with the FDA. What is its potential in allergic care?

New study will look at psychedelics as a treatment for PTSD.

Rodney Wilson, spokesperson from the American Red Cross, offers some final thoughts on how providers can encourage blood donations among their patients.

A spokesperson from American Red Cross discusses the importance of National Blood Donor Month and the challenges faced during the COVID-19 pandemic.

Dr. Matthew Brams presented new data showing the efficacy of CTx-1301 for ADHD.